Literature DB >> 122529

Gold therapy.

J E Levinson, G P Balz, S Bondi.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 122529

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Medical management of children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

2.  Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.

Authors:  E H Giannini; E J Brewer; D A Person
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.

Authors:  O Garcia-Morteo; M E Suarez-Almazor; J A Maldonado-Cocco; R Cuttica; S Abate
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

Review 4.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 5.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.